MANNITOL

MANNITOL was reported 4991 times

MANNITOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARASITIC ENCEPHALITIS 4 0.4444
1 SLEEP DISORDER THERAPY 87 0.4394
2 ANTACID THERAPY 51 0.3923
3 APPENDICOLITH 142 0.3669
4 ANALGESIC THERAPY 90 0.2804
5 DRUG THERAPY 88 0.2596
6 CONGENITAL HIATUS HERNIA 52 0.2281
7 MALIGNANT MELANOMA STAGE 0 44 0.2105
8 CSF VOLUME DECREASED 5 0.1923
9 ANTICOAGULANT THERAPY 52 0.1831
10 PROCALCITONIN DECREASED 12 0.1714
11 BALAMUTHIA INFECTION 4 0.1379
12 PULMONARY SEPTAL THICKENING 12 0.1348
13 TICK-BORNE VIRAL ENCEPHALITIS 8 0.1333
14 BACTEROIDES INFECTION 27 0.1034
15 HYPOTONY MACULOPATHY 4 0.0976
16 ACUTE HAEMORRHAGIC LEUKOENCEPHALITIS 3 0.0833
17 EOSINOPHIL PERCENTAGE DECREASED 12 0.0603
18 HYPERPHOSPHATAEMIA 122 0.0567
19 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 46 0.0496
20 BLOOD PHOSPHORUS INCREASED 132 0.0483
21 BLOOD CREATINE DECREASED 12 0.0397
22 SMALL BOWEL ANGIOEDEMA 4 0.0374
23 DRUG CHEMICAL INCOMPATIBILITY 3 0.0366
24 LEUKOSTASIS SYNDROME 4 0.0301
25 PROPOFOL INFUSION SYNDROME 20 0.0284
26 POSTOPERATIVE RENAL FAILURE 4 0.0276
27 TOXIC NEUROPATHY 10 0.0254
28 RED BLOOD CELLS URINE POSITIVE 24 0.0248
29 CLOSTRIDIAL SEPSIS 6 0.0248
30 HYPEROSMOLAR STATE 7 0.0243
31 SPINAL CORD INJURY CERVICAL 6 0.0238
32 TOXIC OPTIC NEUROPATHY 10 0.0230
33 INCISION SITE PAIN 27 0.0230
34 TUMOUR PERFORATION 7 0.0220
35 TOTAL LUNG CAPACITY DECREASED 35 0.0219
36 AORTIC VALVE CALCIFICATION 11 0.0214
37 ORGANIC BRAIN SYNDROME 4 0.0213
38 DECEREBRATE POSTURE 3 0.0204
39 BLOOD URIC ACID INCREASED 116 0.0201
40 C-REACTIVE PROTEIN DECREASED 13 0.0199
41 HYPOPHOSPHATAEMIA 143 0.0193
42 IRON DEFICIENCY 84 0.0187
43 ELECTROCARDIOGRAM T WAVE PEAKED 7 0.0174
44 MYASTHENIA GRAVIS 140 0.0173
45 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 86 0.0170
46 BLOOD FOLATE DECREASED 12 0.0165
47 PLEURITIC PAIN 45 0.0163
48 FEAR 430 0.0160
49 MULTI-ORGAN FAILURE 276 0.0159
50 BRAIN HERNIATION 46 0.0154
51 APPENDICITIS 142 0.0152
52 FEAR OF DEATH 34 0.0151
53 AORTIC STENOSIS 50 0.0143
54 VENTRICULAR FIBRILLATION 158 0.0142
55 HUMAN HERPESVIRUS 6 ENCEPHALITIS 4 0.0141
56 RESPIRATORY SYMPTOM 40 0.0140
57 ACID BASE BALANCE ABNORMAL 3 0.0134
58 ENTEROBACTER BACTERAEMIA 4 0.0132
59 RENAL INJURY 382 0.0128
60 MENINGITIS TUBERCULOUS 7 0.0125
61 UREAPLASMA INFECTION 5 0.0123
62 BLOOD OSMOLARITY INCREASED 4 0.0122
63 LUNG OPACITY 32 0.0121
64 ANHEDONIA 312 0.0119
65 CYTOMEGALOVIRUS GASTRITIS 3 0.0119
66 CARDIOGENIC SHOCK 163 0.0113
67 BLOOD UREA DECREASED 14 0.0113
68 CHOROIDAL EFFUSION 9 0.0112
69 CATHETER SITE THROMBOSIS 3 0.0109
70 BLOOD CHOLINESTERASE DECREASED 3 0.0109
71 FLOPPY IRIS SYNDROME 4 0.0108
72 NEUROSARCOIDOSIS 4 0.0106
73 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 4 0.0105
74 ENGRAFTMENT SYNDROME 6 0.0102
75 PARVOVIRUS INFECTION 4 0.0099
76 TUMOUR ASSOCIATED FEVER 4 0.0098
77 LEFT ATRIAL DILATATION 12 0.0094
78 MYOGLOBINURIA 5 0.0094
79 COMPLICATIONS OF TRANSPLANTED KIDNEY 21 0.0093
80 TROPONIN INCREASED 70 0.0092
81 BENIGN PROSTATIC HYPERPLASIA 47 0.0091
82 BRAIN DEATH 28 0.0091
83 COAGULATION TIME SHORTENED 3 0.0090
84 BRAIN OEDEMA 112 0.0089
85 GASTROINTESTINAL BACTERIAL INFECTION 10 0.0087
86 PUPILS UNEQUAL 10 0.0087
87 BREATH SOUNDS ABNORMAL 43 0.0087
88 FANCONI SYNDROME 12 0.0085
89 INFECTION IN AN IMMUNOCOMPROMISED HOST 6 0.0084
90 CEREBRAL VENOUS SINUS THROMBOSIS 7 0.0083
91 OPTIC ATROPHY 13 0.0080
92 TOXIC SHOCK SYNDROME 5 0.0079
93 MACULOPATHY 28 0.0079
94 PARAPARESIS 14 0.0079
95 ABDOMINAL COMPARTMENT SYNDROME 5 0.0078
96 CEREBRAL ARTERY THROMBOSIS 4 0.0078
97 CEREBRAL TOXOPLASMOSIS 7 0.0075
98 INCISION SITE IMPAIRED HEALING 3 0.0074
99 MULTIPLE ORGAN DYSFUNCTION SYNDROME 207 0.0073
100 HAEMORRHAGIC TRANSFORMATION STROKE 11 0.0073
101 BLOOD CALCIUM INCREASED 64 0.0073
102 CANDIDA TEST POSITIVE 3 0.0072
103 HAEMORRHAGIC CEREBRAL INFARCTION 5 0.0071
104 BACTERIAL INFECTION 133 0.0071
105 INJURY 495 0.0070
106 DELAYED GRAFT FUNCTION 5 0.0070
107 LYMPHOCYTE MORPHOLOGY ABNORMAL 4 0.0069
108 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 117 0.0068
109 BLOOD CHLORIDE DECREASED 17 0.0066
110 LISTERIOSIS 7 0.0063
111 PARESIS 14 0.0063
112 SUPERIOR SAGITTAL SINUS THROMBOSIS 5 0.0063
113 OPTIC NERVE DISORDER 10 0.0062
114 UNEVALUABLE EVENT 470 0.0062
115 CHEMICAL BURN 7 0.0061
116 CEREBRAL VENOUS THROMBOSIS 11 0.0061
117 HYPERLIPIDAEMIA 70 0.0059
118 EMBOLISM ARTERIAL 7 0.0058
119 PROTEIN URINE PRESENT 29 0.0058
120 BRAIN MIDLINE SHIFT 3 0.0057
121 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
122 HYPERLEUKOCYTOSIS 5 0.0056
123 NEUROLOGICAL DECOMPENSATION 13 0.0056
124 INTRACRANIAL VENOUS SINUS THROMBOSIS 6 0.0056
125 PROTEIN TOTAL DECREASED 21 0.0056
126 INTRACRANIAL PRESSURE INCREASED 31 0.0056
127 NEURALGIA 134 0.0055
128 ANGLE CLOSURE GLAUCOMA 14 0.0055
129 EOSINOPHIL COUNT DECREASED 13 0.0055
130 ASCITES 160 0.0054
131 HYPERNATRAEMIA 27 0.0054
132 CHOROIDAL DETACHMENT 3 0.0054
133 HYPERCHOLESTEROLAEMIA 52 0.0054
134 KLEBSIELLA SEPSIS 6 0.0053
135 KLEBSIELLA BACTERAEMIA 5 0.0053
136 CREATINE KINASE INCREASED 4 0.0052
137 CRYSTAL NEPHROPATHY 3 0.0051
138 ACIDOSIS HYPERCHLORAEMIC 3 0.0051
139 INCISION SITE HAEMORRHAGE 4 0.0049
140 END STAGE RENAL DISEASE 90 0.0049
141 CARDIOVASCULAR INSUFFICIENCY 8 0.0049
142 CONSCIOUSNESS FLUCTUATING 5 0.0048
143 BILIRUBIN CONJUGATED INCREASED 11 0.0047
144 HYPERCHLORAEMIA 3 0.0047
145 RENAL IMPAIRMENT 394 0.0047
146 ENTEROCOCCUS TEST POSITIVE 3 0.0046
147 THALAMUS HAEMORRHAGE 4 0.0046
148 DIABETES INSIPIDUS 11 0.0046
149 BLOOD ALBUMIN DECREASED 36 0.0045
150 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
151 BLOOD TEST ABNORMAL 63 0.0045
152 BLOOD UREA INCREASED 75 0.0045
153 ULCER 71 0.0045
154 RENAL FAILURE 592 0.0045
155 HYPONATRAEMIA 251 0.0045
156 ASPIRATION 48 0.0044
157 RENAL FAILURE ACUTE 184 0.0043
158 SKIN GRAFT 4 0.0043
159 SKIN TEST POSITIVE 4 0.0043
160 ALLODYNIA 5 0.0043
161 NEUTROPENIC INFECTION 4 0.0042
162 ENTEROBACTER INFECTION 7 0.0042
163 SUPRAVENTRICULAR EXTRASYSTOLES 14 0.0041
164 BRAIN CONTUSION 3 0.0041
165 PUPIL FIXED 7 0.0040
166 HIGH DENSITY LIPOPROTEIN INCREASED 4 0.0040
167 LIVER ABSCESS 13 0.0040
168 TRANSPLANT DYSFUNCTION 7 0.0039
169 GOUT 70 0.0039
170 CONJUNCTIVAL OEDEMA 4 0.0039
171 EXTRADURAL ABSCESS 3 0.0038
172 BLOOD FIBRINOGEN INCREASED 3 0.0038
173 FULL BLOOD COUNT ABNORMAL 40 0.0038
174 PUPILLARY REFLEX IMPAIRED 7 0.0038
175 MICTURITION URGENCY 43 0.0038
176 AREFLEXIA 10 0.0037
177 ORGAN FAILURE 15 0.0037
178 BLOOD SODIUM INCREASED 10 0.0037
179 RHONCHI 5 0.0036
180 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
181 QUADRIPARESIS 6 0.0036
182 BRAIN ABSCESS 9 0.0036
183 NEUTROPHIL COUNT INCREASED 36 0.0035
184 HAEMODYNAMIC INSTABILITY 26 0.0034
185 BLOOD ALBUMIN INCREASED 3 0.0034
186 KLEBSIELLA INFECTION 17 0.0034
187 ANAEMIA OF CHRONIC DISEASE 3 0.0033
188 CEREBRAL ARTERY EMBOLISM 4 0.0033
189 LYMPHOCYTE COUNT DECREASED 58 0.0033
190 VENTRICULAR ARRHYTHMIA 12 0.0033
191 RALES 19 0.0033
192 BLOOD MAGNESIUM DECREASED 28 0.0032
193 TACHYARRHYTHMIA 8 0.0032
194 BLOOD UREA ABNORMAL 3 0.0032
195 EMOTIONAL DISTRESS 386 0.0032
196 DELAYED RECOVERY FROM ANAESTHESIA 3 0.0032
197 TUMOUR HAEMORRHAGE 9 0.0032
198 HYPERCOAGULATION 6 0.0031
199 BILE DUCT STONE 10 0.0031
200 PSEUDOMEMBRANOUS COLITIS 7 0.0031
201 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
202 HYDROCEPHALUS 17 0.0031
203 GAZE PALSY 5 0.0029
204 CENTRAL NERVOUS SYSTEM LYMPHOMA 4 0.0029
205 RENAL FAILURE CHRONIC 22 0.0029
206 FANCONI SYNDROME ACQUIRED 5 0.0028
207 HEPARIN-INDUCED THROMBOCYTOPENIA 14 0.0028
208 PRERENAL FAILURE 4 0.0028
209 LUMBAR VERTEBRAL FRACTURE 13 0.0028
210 HYPERPARATHYROIDISM SECONDARY 7 0.0028
211 BLOOD CREATININE INCREASED 182 0.0028
212 VASCULAR INJURY 4 0.0028
213 RENAL INFARCT 4 0.0028
214 PNEUMONIA KLEBSIELLA 5 0.0027
215 KIDNEY TRANSPLANT REJECTION 13 0.0027
216 CORNEAL OEDEMA 6 0.0027
217 HYPERURICAEMIA 11 0.0027
218 PSYCHOLOGICAL TRAUMA 23 0.0027
219 NEPHROGENIC SYSTEMIC FIBROSIS 8 0.0026
220 LUNG INFILTRATION 23 0.0026
221 REACTION TO EXCIPIENT 6 0.0026
222 CYTOMEGALOVIRUS CHORIORETINITIS 5 0.0026
223 TRANSAMINASES INCREASED 57 0.0026
224 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
225 APLASIA 5 0.0026
226 BLOOD CHOLESTEROL INCREASED 119 0.0026
227 HYPERKALAEMIA 89 0.0025
228 URINE OUTPUT DECREASED 22 0.0025
229 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 130 0.0025
230 ENCEPHALITIS VIRAL 3 0.0025
231 HYPOALBUMINAEMIA 19 0.0024
232 SEPSIS 271 0.0024
233 QUADRIPLEGIA 5 0.0024
234 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
235 SKIN INDURATION 5 0.0024
236 CEREBRAL HAEMATOMA 8 0.0024
237 POST PROCEDURAL HAEMATOMA 4 0.0024
238 NECROSIS 13 0.0023
239 LYMPHOCYTOSIS 5 0.0023
240 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 22 0.0023
241 HYPERAMMONAEMIC ENCEPHALOPATHY 4 0.0023
242 EXTREMITY NECROSIS 4 0.0023
243 VENOUS THROMBOSIS 9 0.0023
244 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
245 HEMIPLEGIA 19 0.0023
246 ATAXIA 27 0.0023
247 EXTRADURAL HAEMATOMA 3 0.0023
248 SUBARACHNOID HAEMORRHAGE 23 0.0023
249 INTESTINAL DILATATION 3 0.0022
250 CIRCULATORY COLLAPSE 38 0.0022
251 NEPHROPATHY TOXIC 25 0.0022
252 HYPERTRIGLYCERIDAEMIA 13 0.0022
253 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
254 MONOPARESIS 4 0.0022
255 CEREBRAL HAEMORRHAGE 79 0.0022
256 VENTRICULAR HYPOKINESIA 7 0.0022
257 OTOTOXICITY 4 0.0022
258 NEPHROGENIC ANAEMIA 10 0.0022
259 HYPOPROTEINAEMIA 4 0.0021
260 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
261 POLYURIA 17 0.0021
262 JOINT INJURY 44 0.0021
263 BRONCHOPNEUMONIA 7 0.0020
264 VIITH NERVE PARALYSIS 7 0.0020
265 HYPERTHERMIA MALIGNANT 3 0.0020
266 URINE ANALYSIS ABNORMAL 6 0.0020
267 MIXED LIVER INJURY 6 0.0020
268 HYPOKALAEMIA 92 0.0020
269 VISUAL FIELD DEFECT 14 0.0019
270 RENAL TUBULAR NECROSIS 19 0.0019
271 OLIGURIA 12 0.0019
272 DIABETES MELLITUS 145 0.0019
273 PSYCHIATRIC SYMPTOM 14 0.0019
274 ELECTROLYTE IMBALANCE 22 0.0019
275 LOW BIRTH WEIGHT BABY 15 0.0019
276 CORONARY ARTERY DISEASE 57 0.0019
277 GENERAL PHYSICAL HEALTH DETERIORATION 216 0.0019
278 COMPRESSION FRACTURE 10 0.0019
279 LANGUAGE DISORDER 4 0.0018
280 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
281 REACTION TO DRUG EXCIPIENTS 4 0.0018
282 ACIDOSIS 14 0.0018
283 THROMBOSIS 147 0.0018
284 DEAFNESS NEUROSENSORY 6 0.0018
285 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
286 VENTRICULAR TACHYCARDIA 30 0.0018
287 NOSOCOMIAL INFECTION 4 0.0018
288 HYPERAMMONAEMIA 9 0.0018
289 CARDIOPULMONARY FAILURE 7 0.0018
290 TORSADE DE POINTES 14 0.0018
291 BRONCHIECTASIS 12 0.0018
292 ANXIETY 505 0.0018
293 DISABILITY 35 0.0018
294 PULMONARY EMBOLISM 168 0.0018
295 CEREBRAL INFARCTION 43 0.0018
296 METASTASES TO MENINGES 4 0.0018
297 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
298 PHLEBITIS 9 0.0018
299 SLEEP DISORDER 124 0.0018
300 DRY MOUTH 141 0.0017
301 BLOOD CHLORIDE INCREASED 3 0.0017
302 ABDOMINAL DISTENSION 181 0.0017
303 IRON DEFICIENCY ANAEMIA 16 0.0017
304 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
305 TUMOUR LYSIS SYNDROME 15 0.0017
306 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 10 0.0017
307 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
308 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
309 HYPERPYREXIA 7 0.0017
310 BLOOD PHOSPHORUS DECREASED 6 0.0016
311 INTESTINAL ISCHAEMIA 9 0.0016
312 ISCHAEMIC STROKE 29 0.0016
313 STAPHYLOCOCCAL SEPSIS 8 0.0016
314 TACHYPNOEA 22 0.0016
315 CARDIOVASCULAR DISORDER 41 0.0016
316 ABDOMINAL TENDERNESS 8 0.0016
317 LOWER RESPIRATORY TRACT INFECTION 73 0.0016
318 LABYRINTHITIS 4 0.0016
319 HYPOMAGNESAEMIA 22 0.0016
320 CARDIOTOXICITY 14 0.0016
321 INTENTIONAL PRODUCT MISUSE 136 0.0016
322 METASTASES TO CENTRAL NERVOUS SYSTEM 20 0.0015
323 HAEMODIALYSIS 13 0.0015
324 WHITE BLOOD CELL COUNT INCREASED 59 0.0015
325 SUBDURAL HAEMATOMA 22 0.0015
326 BACTERIAL SEPSIS 5 0.0015
327 HEMIPARESIS 26 0.0015
328 COMA 73 0.0015
329 BONE MARROW FAILURE 31 0.0015
330 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
331 SWELLING 142 0.0015
332 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
333 RENAL FUNCTION TEST ABNORMAL 7 0.0015
334 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
335 HYPERLACTACIDAEMIA 4 0.0015
336 DEVICE RELATED SEPSIS 3 0.0015
337 HAEMORRHAGE INTRACRANIAL 22 0.0015
338 SUDDEN CARDIAC DEATH 5 0.0015
339 SUBDURAL HAEMORRHAGE 4 0.0015
340 ANAEMIA 278 0.0015
341 WOUND COMPLICATION 5 0.0015
342 C-REACTIVE PROTEIN INCREASED 53 0.0015
343 RED BLOOD CELL COUNT INCREASED 4 0.0014
344 HEPATIC FUNCTION ABNORMAL 54 0.0014
345 DRUG INTOLERANCE 138 0.0014
346 TYPE I HYPERSENSITIVITY 5 0.0014
347 STATUS EPILEPTICUS 16 0.0014
348 PLEURAL EFFUSION 86 0.0014
349 PNEUMATOSIS INTESTINALIS 4 0.0014
350 DERMATITIS EXFOLIATIVE 7 0.0014
351 ASPARTATE AMINOTRANSFERASE INCREASED 74 0.0014
352 PARAPLEGIA 4 0.0014
353 ENCEPHALOPATHY 34 0.0014
354 CYTOMEGALOVIRUS INFECTION 23 0.0014
355 HAEMOTHORAX 4 0.0014
356 GASTROINTESTINAL NECROSIS 4 0.0014
357 SPUTUM DISCOLOURED 13 0.0014
358 PARONYCHIA 6 0.0014
359 LIVER FUNCTION TEST INCREASED 29 0.0013
360 BACTERIAL TEST POSITIVE 3 0.0013
361 RESPIRATORY FAILURE 98 0.0013
362 LEUKOENCEPHALOPATHY 5 0.0013
363 TRANSIENT ISCHAEMIC ATTACK 45 0.0013
364 METABOLIC ENCEPHALOPATHY 4 0.0013
365 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
366 HAEMOPTYSIS 37 0.0013
367 CENTRAL VENOUS CATHETERISATION 4 0.0013
368 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
369 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
370 METABOLIC ACIDOSIS 42 0.0013
371 GRAND MAL CONVULSION 12 0.0013
372 PULMONARY HAEMORRHAGE 10 0.0013
373 BLOOD CREATININE DECREASED 4 0.0013
374 CYANOSIS 20 0.0013
375 OESOPHAGEAL CANDIDIASIS 5 0.0013
376 ACUTE PULMONARY OEDEMA 7 0.0012
377 ATELECTASIS 12 0.0012
378 ENTEROCOCCAL INFECTION 6 0.0012
379 ANAPHYLACTIC SHOCK 32 0.0012
380 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
381 NEUROLOGICAL SYMPTOM 7 0.0012
382 PERIPHERAL ISCHAEMIA 5 0.0012
383 EXTRAVASATION 5 0.0012
384 UPPER RESPIRATORY TRACT INFECTION 56 0.0012
385 DRUG-INDUCED LIVER INJURY 38 0.0012
386 APPETITE DISORDER 8 0.0012
387 GASTROINTESTINAL PERFORATION 5 0.0012
388 MENINGITIS 8 0.0012
389 BRAIN INJURY 12 0.0012
390 METASTASES TO SPINE 4 0.0012
391 TONGUE ULCERATION 4 0.0012
392 BACTERAEMIA 14 0.0012
393 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
394 CARDIAC ARREST 96 0.0012
395 LYMPHOEDEMA 8 0.0012
396 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
397 COAGULOPATHY 19 0.0011
398 PAPULE 8 0.0011
399 BLOOD CREATINE INCREASED 5 0.0011
400 ALANINE AMINOTRANSFERASE INCREASED 69 0.0011
401 CONJUNCTIVAL HYPERAEMIA 4 0.0011
402 ILEUS PARALYTIC 5 0.0011
403 ANAESTHETIC COMPLICATION 3 0.0011
404 GASTROINTESTINAL INJURY 3 0.0011
405 SOMNOLENCE 223 0.0011
406 RENAL TRANSPLANT 4 0.0011
407 HICCUPS 9 0.0011
408 INTRAOCULAR PRESSURE INCREASED 14 0.0011
409 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
410 BLOOD POTASSIUM DECREASED 32 0.0011
411 HEPATIC NECROSIS 4 0.0011
412 LEUKOPENIA 53 0.0011
413 VENTRICULAR EXTRASYSTOLES 11 0.0011
414 PARALYSIS 15 0.0010
415 PROCEDURAL COMPLICATION 8 0.0010
416 LIVER DISORDER 46 0.0010
417 SINUS BRADYCARDIA 10 0.0010
418 PRODUCT LABEL CONFUSION 6 0.0010
419 APNOEA 8 0.0010
420 HAEMORRHAGIC STROKE 8 0.0010
421 THROMBOCYTOPENIA 114 0.0010
422 CONSTIPATION 222 0.0010
423 PAIN 623 0.0010
424 ODYNOPHAGIA 6 0.0010
425 CEREBRAL ATROPHY 4 0.0010
426 PROTHROMBIN TIME PROLONGED 6 0.0010
427 CONDITION AGGRAVATED 305 0.0010
428 AZOTAEMIA 4 0.0010
429 LUNG DISORDER 49 0.0010
430 CANDIDIASIS 4 0.0010
431 FEBRILE NEUTROPENIA 66 0.0010
432 MUCOSAL INFLAMMATION 26 0.0010
433 HYPERGLYCAEMIA 36 0.0010
434 NEUTROPHIL COUNT DECREASED 40 0.0010
435 ENDOCARDITIS 5 0.0010
436 ANAPHYLACTOID REACTION 4 0.0010
437 CEREBRAL ISCHAEMIA 5 0.0010
438 PERIPHERAL VASCULAR DISORDER 5 0.0010
439 TEMPERATURE INTOLERANCE 10 0.0010
440 AGRANULOCYTOSIS 18 0.0010
441 HYPOXIA 34 0.0010
442 FOETAL DEATH 5 0.0010
443 APHASIA 29 0.0010
444 NYSTAGMUS 5 0.0009
445 FEBRILE BONE MARROW APLASIA 4 0.0009
446 PULMONARY MASS 14 0.0009
447 PULMONARY OEDEMA 42 0.0009
448 POST PROCEDURAL COMPLICATION 18 0.0009
449 MYDRIASIS 12 0.0009
450 CARDIO-RESPIRATORY ARREST 39 0.0009
451 PANCYTOPENIA 52 0.0009
452 UNRESPONSIVE TO STIMULI 24 0.0009
453 PLATELET COUNT DECREASED 99 0.0009
454 HEPATITIS ACUTE 6 0.0009
455 HYPOVENTILATION 3 0.0009
456 OESOPHAGITIS 10 0.0009
457 ABDOMINAL PAIN 212 0.0009
458 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
459 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
460 MENTAL STATUS CHANGES 25 0.0009
461 HYPOCALCAEMIA 17 0.0009
462 ANXIETY DISORDER 3 0.0009
463 CARDIAC FAILURE 72 0.0009
464 MALNUTRITION 10 0.0009
465 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 49 0.0009
466 BK VIRUS INFECTION 3 0.0009
467 BLOOD BILIRUBIN INCREASED 24 0.0009
468 CLOSTRIDIAL INFECTION 3 0.0009
469 PAPILLOEDEMA 4 0.0009
470 EPILEPSY 27 0.0009
471 SHOCK 20 0.0009
472 OEDEMA PERIPHERAL 105 0.0009
473 DISORIENTATION 34 0.0009
474 HAEMATOCRIT DECREASED 17 0.0009
475 DEFORMITY 8 0.0009
476 DEPRESSION 194 0.0009
477 DIALYSIS 12 0.0008
478 FIBRIN D DIMER INCREASED 3 0.0008
479 HAEMORRHAGIC DIATHESIS 3 0.0008
480 RETINAL HAEMORRHAGE 6 0.0008
481 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
482 NEUTROPENIC SEPSIS 6 0.0008
483 NON-SMALL CELL LUNG CANCER 4 0.0008
484 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
485 GASTROINTESTINAL TOXICITY 4 0.0008
486 CAROTID ARTERY OCCLUSION 3 0.0008
487 FACIAL PARALYSIS 7 0.0008
488 HEPATOMEGALY 8 0.0008
489 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
490 MUSCULOSKELETAL STIFFNESS 71 0.0008
491 SEPTIC SHOCK 35 0.0008
492 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 4 0.0008
493 HYDRONEPHROSIS 6 0.0008
494 THERAPY NON-RESPONDER 36 0.0008
495 PNEUMONIA ASPIRATION 20 0.0008
496 CHRONIC SINUSITIS 3 0.0008
497 HEPATIC FAILURE 24 0.0008
498 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
499 HAEMOGLOBIN DECREASED 81 0.0008
500 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
501 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
502 PROCTALGIA 5 0.0008
503 HYPOTENSION 156 0.0008
504 RASH ERYTHEMATOUS 37 0.0008
505 LUNG INFECTION 12 0.0008
506 BLOOD PRESSURE DECREASED 51 0.0008
507 CEREBROVASCULAR ACCIDENT 130 0.0008
508 ACUTE KIDNEY INJURY 117 0.0008
509 PARTIAL SEIZURES 4 0.0008
510 HYPERTHYROIDISM 11 0.0008
511 ORAL CANDIDIASIS 10 0.0008
512 POLYARTHRITIS 4 0.0008
513 CARDIAC FAILURE ACUTE 5 0.0007
514 ARTERIOSPASM CORONARY 3 0.0007
515 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
516 ANAL ABSCESS 4 0.0007
517 POSTOPERATIVE WOUND INFECTION 5 0.0007
518 DRUG RESISTANCE 19 0.0007
519 BRADYCARDIA 39 0.0007
520 PALLOR 20 0.0007
521 ESCHERICHIA INFECTION 6 0.0007
522 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
523 NERVOUSNESS 38 0.0007
524 RESPIRATION ABNORMAL 5 0.0007
525 RESPIRATORY DISTRESS 20 0.0007
526 ENCEPHALITIS 5 0.0007
527 MYELOSUPPRESSION 26 0.0007
528 VOMITING 338 0.0007
529 LEUKOCYTOSIS 13 0.0007
530 PELVIC PAIN 13 0.0007
531 GASTROINTESTINAL DISORDER 64 0.0007
532 LYMPHOPENIA 10 0.0007
533 SINUS TACHYCARDIA 10 0.0007
534 GRANULOCYTOPENIA 4 0.0007
535 HYPOTONIA 7 0.0007
536 PSEUDOMONAS INFECTION 6 0.0007
537 CYTOKINE RELEASE SYNDROME 14 0.0007
538 PNEUMONITIS 19 0.0007
539 ANAPHYLACTIC REACTION 38 0.0007
540 POST PROCEDURAL HAEMORRHAGE 8 0.0007
541 FLUID OVERLOAD 10 0.0007
542 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
543 PULMONARY FIBROSIS 13 0.0007
544 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
545 DRUG ERUPTION 12 0.0007
546 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
547 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
548 HYPOAESTHESIA ORAL 10 0.0007
549 ABDOMINAL HERNIA 3 0.0007
550 WHITE BLOOD CELL COUNT DECREASED 71 0.0007
551 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
552 BRAIN NEOPLASM 6 0.0007
553 RESPIRATORY DEPRESSION 8 0.0007
554 DEVICE RELATED INFECTION 10 0.0006
555 LARYNGEAL OEDEMA 4 0.0006
556 HAEMATURIA 22 0.0006
557 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
558 BLEPHAROSPASM 4 0.0006
559 HEPATOCELLULAR INJURY 9 0.0006
560 COLITIS 24 0.0006
561 DRUG SCREEN POSITIVE 5 0.0006
562 DEEP VEIN THROMBOSIS 41 0.0006
563 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
564 HYPOVOLAEMIC SHOCK 3 0.0006
565 FAECAL INCONTINENCE 3 0.0006
566 PARAESTHESIA ORAL 9 0.0006
567 ACUTE RESPIRATORY FAILURE 12 0.0006
568 INTESTINAL PERFORATION 7 0.0006
569 HYPERTENSION 132 0.0006
570 BLOOD CALCIUM DECREASED 7 0.0006
571 ATRIAL FIBRILLATION 60 0.0006
572 DECUBITUS ULCER 5 0.0006
573 PROCEDURAL PAIN 17 0.0006
574 PYREXIA 212 0.0006
575 BRADYPHRENIA 4 0.0006
576 CARDIOMYOPATHY 9 0.0006
577 HYPERVOLAEMIA 3 0.0006
578 DIABETIC NEUROPATHY 3 0.0006
579 INFLAMMATORY MARKER INCREASED 3 0.0006
580 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
581 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
582 NEUTROPENIA 82 0.0006
583 EMBOLISM 5 0.0006
584 RHABDOMYOLYSIS 25 0.0006
585 AGITATION 44 0.0006
586 SKIN MASS 4 0.0006
587 HEART RATE DECREASED 21 0.0006
588 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
589 JAUNDICE 16 0.0006
590 COLITIS ISCHAEMIC 4 0.0006
591 ARRHYTHMIA 28 0.0006
592 ACUTE HEPATIC FAILURE 8 0.0006
593 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
594 DYSARTHRIA 22 0.0006
595 BLOOD URINE PRESENT 11 0.0006
596 LARGE INTESTINE PERFORATION 4 0.0006
597 HYPERTRANSAMINASAEMIA 4 0.0006
598 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
599 CYTOPENIA 7 0.0006
600 NEUROTOXICITY 10 0.0006
601 PNEUMOTHORAX 9 0.0006
602 COLD SWEAT 10 0.0006
603 PREMATURE DELIVERY 9 0.0006
604 PHARYNGITIS 7 0.0006
605 ILEUS 7 0.0006
606 CHILLS 66 0.0006
607 WRONG DRUG ADMINISTERED 5 0.0006
608 GINGIVITIS 3 0.0006
609 LACTIC ACIDOSIS 18 0.0006
610 DRUG INTERACTION 88 0.0006
611 CHEILITIS 3 0.0006
612 PRODUCT USE IN UNAPPROVED INDICATION 137 0.0006
613 DERMATITIS BULLOUS 4 0.0006
614 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
615 RASH PUSTULAR 4 0.0005
616 GASTROENTERITIS 8 0.0005
617 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
618 TACHYCARDIA 48 0.0005
619 DYSPHAGIA 51 0.0005
620 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
621 DEHYDRATION 71 0.0005
622 GASTRITIS 14 0.0005
623 PREMATURE BABY 16 0.0005
624 BLOOD SODIUM DECREASED 10 0.0005
625 LIVER INJURY 13 0.0005
626 CHOLECYSTITIS ACUTE 3 0.0005
627 HYPERTHERMIA 4 0.0005
628 HYPERTONIA 3 0.0005
629 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
630 LIPASE INCREASED 4 0.0005
631 HERPES VIRUS INFECTION 3 0.0005
632 GLAUCOMA 10 0.0005
633 EMOTIONAL DISORDER 16 0.0005
634 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
635 DRUG TOXICITY 7 0.0005
636 THROMBOTIC MICROANGIOPATHY 5 0.0005
637 HYPOVOLAEMIA 3 0.0005
638 MENINGIOMA 8 0.0005
639 SPLENOMEGALY 6 0.0005
640 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
641 URINARY RETENTION 17 0.0005
642 CONVULSION 29 0.0005
643 MENTAL DISORDER 22 0.0005
644 RENAL CYST 4 0.0005
645 MYOCLONUS 6 0.0005
646 ATRIAL FLUTTER 4 0.0005
647 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
648 TRANSPLANT REJECTION 4 0.0005
649 CHEST DISCOMFORT 51 0.0005
650 GANGRENE 3 0.0005
651 DEAFNESS 13 0.0005
652 DEATH 428 0.0005
653 RASH MACULO-PAPULAR 11 0.0005
654 MUSCLE DISORDER 4 0.0005
655 FOETAL GROWTH RESTRICTION 3 0.0005
656 SHOCK HAEMORRHAGIC 4 0.0005
657 DISEASE PROGRESSION 58 0.0005
658 CHRONIC KIDNEY DISEASE 37 0.0005
659 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
660 CONJUNCTIVITIS 9 0.0005
661 PNEUMONIA 157 0.0005
662 CHOLANGITIS 3 0.0005
663 LIVER FUNCTION TEST ABNORMAL 14 0.0005
664 NERVOUS SYSTEM DISORDER 15 0.0005
665 PETECHIAE 5 0.0005
666 DERMATITIS ALLERGIC 6 0.0005
667 SEIZURE 55 0.0005
668 TREMOR 78 0.0005
669 SEROTONIN SYNDROME 9 0.0005
670 MUSCULAR WEAKNESS 53 0.0005
671 ANURIA 4 0.0005
672 DYSTONIA 9 0.0005
673 OXYGEN SATURATION DECREASED 26 0.0005
674 CARDIAC MURMUR 4 0.0005
675 DYSURIA 17 0.0005
676 PLATELET COUNT INCREASED 6 0.0005
677 DISCOMFORT 28 0.0005
678 OFF LABEL USE 400 0.0005
679 DENTAL CARIES 5 0.0005
680 STEVENS-JOHNSON SYNDROME 10 0.0004
681 NAUSEA 356 0.0004
682 HYPERTENSIVE CRISIS 5 0.0004
683 PANCREATITIS ACUTE 10 0.0004
684 FEEDING DISORDER 9 0.0004
685 OEDEMA 24 0.0004
686 MITRAL VALVE INCOMPETENCE 5 0.0004
687 RESTLESS LEGS SYNDROME 8 0.0004
688 LOSS OF CONSCIOUSNESS 56 0.0004
689 RESPIRATORY ARREST 12 0.0004
690 GASTRIC HAEMORRHAGE 5 0.0004
691 HAEMATEMESIS 11 0.0004
692 ASTHMA 49 0.0004
693 AUTOIMMUNE HEPATITIS 3 0.0004
694 COORDINATION ABNORMAL 6 0.0004
695 HEPATITIS 11 0.0004
696 EXTRASYSTOLES 3 0.0004
697 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
698 ERYTHEMA MULTIFORME 4 0.0004
699 NEPHROPATHY 4 0.0004
700 MOUTH ULCERATION 9 0.0004
701 FLANK PAIN 4 0.0004
702 ARTERIOSCLEROSIS 4 0.0004
703 ABORTION INDUCED 4 0.0004
704 SPEECH DISORDER 22 0.0004
705 DYSKINESIA 17 0.0004
706 MUSCLE RIGIDITY 5 0.0004
707 GRAFT VERSUS HOST DISEASE 3 0.0004
708 DYSPNOEA 235 0.0004
709 ADRENAL INSUFFICIENCY 5 0.0004
710 GENERALISED OEDEMA 5 0.0004
711 RESPIRATORY DISORDER 12 0.0004
712 CHOLELITHIASIS 13 0.0004
713 ASTHENIA 149 0.0004
714 HYPOTHERMIA 4 0.0004
715 STAPHYLOCOCCAL INFECTION 13 0.0004
716 MALIGNANT NEOPLASM PROGRESSION 40 0.0004
717 PERICARDIAL EFFUSION 9 0.0004
718 HAEMOLYSIS 3 0.0004
719 MUSCULOSKELETAL CHEST PAIN 6 0.0004
720 EXPOSURE DURING PREGNANCY 24 0.0004
721 EJECTION FRACTION DECREASED 6 0.0004
722 HAEMATOMA 10 0.0004
723 THERAPY PARTIAL RESPONDER 6 0.0004
724 INCONTINENCE 4 0.0004
725 BLOOD PRESSURE FLUCTUATION 9 0.0004
726 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
727 DRUG INEFFECTIVE 488 0.0004
728 PROTEINURIA 7 0.0004
729 ASPHYXIA 3 0.0004
730 SLEEP APNOEA SYNDROME 7 0.0004
731 METASTASES TO BONE 6 0.0004
732 WOUND INFECTION 4 0.0004
733 HYPERAESTHESIA 3 0.0004
734 LETHARGY 21 0.0004
735 INFUSION SITE ERYTHEMA 3 0.0004
736 FACE OEDEMA 6 0.0004
737 CANDIDA INFECTION 6 0.0004
738 REBOUND EFFECT 4 0.0004
739 MYOCARDIAL ISCHAEMIA 4 0.0004
740 SCAR 6 0.0004
741 BRONCHOSPASM 5 0.0004
742 MUSCLE TWITCHING 8 0.0003
743 DIPLOPIA 9 0.0003
744 MYOCARDIAL INFARCTION 60 0.0003
745 BODY TEMPERATURE INCREASED 7 0.0003
746 EOSINOPHILIA 6 0.0003
747 ACUTE MYOCARDIAL INFARCTION 10 0.0003
748 PERITONITIS 7 0.0003
749 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
750 PULMONARY HYPERTENSION 7 0.0003
751 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
752 POLYNEUROPATHY 4 0.0003
753 MENTAL IMPAIRMENT 8 0.0003
754 SYNCOPE 33 0.0003
755 STOMATITIS 20 0.0003
756 NO THERAPEUTIC RESPONSE 4 0.0003
757 CARDIOMEGALY 4 0.0003
758 MUSCULOSKELETAL PAIN 17 0.0003
759 HYPERCALCAEMIA 4 0.0003
760 HEPATIC STEATOSIS 6 0.0003
761 HEPATIC ENCEPHALOPATHY 3 0.0003
762 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
763 TOXICITY TO VARIOUS AGENTS 54 0.0003
764 SECRETION DISCHARGE 4 0.0003
765 MELAENA 7 0.0003
766 DELIRIUM 11 0.0003
767 NEOPLASM PROGRESSION 11 0.0003
768 HAEMATOTOXICITY 3 0.0003
769 GASTRIC ULCER 6 0.0003
770 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
771 MUSCULOSKELETAL DISORDER 6 0.0003
772 RED BLOOD CELL COUNT DECREASED 9 0.0003
773 ERYTHEMA 64 0.0003
774 INFUSION SITE PAIN 4 0.0003
775 ANOREXIA 4 0.0003
776 INTERSTITIAL LUNG DISEASE 15 0.0003
777 DYSSTASIA 9 0.0003
778 HEPATIC ENZYME INCREASED 21 0.0003
779 BLOOD POTASSIUM INCREASED 5 0.0003
780 RASH 134 0.0003
781 SKIN DISCOLOURATION 14 0.0003
782 HOSPICE CARE 3 0.0003
783 WHEEZING 18 0.0003
784 HEART RATE INCREASED 30 0.0003
785 PRURITUS 116 0.0003
786 BLOOD PRESSURE ABNORMAL 6 0.0003
787 VISUAL ACUITY REDUCED 10 0.0003
788 RESTLESSNESS 11 0.0003
789 EYE HAEMORRHAGE 4 0.0003
790 JOINT RANGE OF MOTION DECREASED 4 0.0003
791 EMPHYSEMA 3 0.0003
792 DECREASED APPETITE 69 0.0003
793 RASH PRURITIC 16 0.0003
794 PERIPHERAL COLDNESS 4 0.0003
795 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
796 HYPERBILIRUBINAEMIA 3 0.0003
797 HYPOGLYCAEMIA 14 0.0003
798 HAEMORRHAGE 30 0.0003
799 CARDIAC FAILURE CONGESTIVE 23 0.0003
800 BLINDNESS UNILATERAL 4 0.0003
801 EPISTAXIS 21 0.0003
802 MOVEMENT DISORDER 9 0.0003
803 ABDOMINAL PAIN LOWER 7 0.0003
804 TOOTHACHE 5 0.0003
805 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
806 NEUROPATHY PERIPHERAL 26 0.0003
807 GASTROINTESTINAL PAIN 3 0.0003
808 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49 0.0003
809 INFUSION RELATED REACTION 18 0.0003
810 LIP SWELLING 9 0.0003
811 ORAL PAIN 6 0.0003
812 FISTULA 3 0.0003
813 PHOTOPHOBIA 5 0.0003
814 CONFUSIONAL STATE 42 0.0003
815 HEADACHE 162 0.0003
816 CELLULITIS 13 0.0003
817 DELUSION 4 0.0003
818 ACUTE MYELOID LEUKAEMIA 4 0.0003
819 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
820 HYPERSENSITIVITY 47 0.0003
821 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
822 HALLUCINATION 19 0.0003
823 HYPERHIDROSIS 32 0.0002
824 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
825 URINARY TRACT INFECTION 42 0.0002
826 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
827 DRUG LEVEL INCREASED 4 0.0002
828 HAIR COLOUR CHANGES 3 0.0002
829 INTESTINAL OBSTRUCTION 9 0.0002
830 DERMATITIS 5 0.0002
831 URINARY INCONTINENCE 7 0.0002
832 MATERNAL EXPOSURE DURING PREGNANCY 21 0.0002
833 HEPATIC CYTOLYSIS 3 0.0002
834 CARDIAC DISORDER 22 0.0002
835 MEDICATION ERROR 13 0.0002
836 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
837 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
838 BALANCE DISORDER 20 0.0002
839 PLASMA CELL MYELOMA 9 0.0002
840 PALPITATIONS 27 0.0002
841 RESPIRATORY TRACT INFECTION 6 0.0002
842 PRODUCT PRESCRIBING ISSUE 5 0.0002
843 LOCAL SWELLING 4 0.0002
844 FEELING HOT 14 0.0002
845 HEAD DISCOMFORT 4 0.0002
846 HAIR TEXTURE ABNORMAL 3 0.0002
847 DYSPHONIA 13 0.0002
848 CHROMATURIA 5 0.0002
849 GINGIVAL BLEEDING 3 0.0002
850 OSTEOPOROSIS 9 0.0002
851 TINNITUS 10 0.0002
852 BLOOD GLUCOSE INCREASED 41 0.0002
853 AMNESIA 14 0.0002
854 RENAL DISORDER 10 0.0002
855 THERAPEUTIC RESPONSE DECREASED 13 0.0002
856 INFECTION 31 0.0002
857 HYPOAESTHESIA 32 0.0002
858 BLISTER 12 0.0002
859 DYSPNOEA EXERTIONAL 8 0.0002
860 VIRAL INFECTION 7 0.0002
861 PRODUCTIVE COUGH 10 0.0002
862 DIABETIC KETOACIDOSIS 5 0.0002
863 ADVERSE EVENT 19 0.0002
864 ORAL HERPES 4 0.0002
865 PSYCHOTIC DISORDER 6 0.0002
866 DIARRHOEA 129 0.0002
867 ABDOMINAL PAIN UPPER 41 0.0002
868 LYMPHADENOPATHY 7 0.0002
869 NECK PAIN 11 0.0002
870 HYPOPHAGIA 5 0.0002
871 DRUG ADMINISTRATION ERROR 6 0.0002
872 RIB FRACTURE 4 0.0002
873 ANKLE FRACTURE 3 0.0002
874 BACK PAIN 45 0.0002
875 COUGH 54 0.0002
876 POLLAKIURIA 8 0.0002
877 FATIGUE 149 0.0002
878 HYPOTHYROIDISM 6 0.0002
879 IMPAIRED WORK ABILITY 4 0.0002
880 POOR QUALITY SLEEP 4 0.0002
881 CATARACT 11 0.0002
882 CHEST PAIN 34 0.0002
883 SKIN LESION 5 0.0002
884 ILL-DEFINED DISORDER 11 0.0002
885 HEPATOTOXICITY 4 0.0002
886 FEELING COLD 5 0.0002
887 FLUSHING 18 0.0002
888 BLOOD PRESSURE INCREASED 27 0.0002
889 BLINDNESS 7 0.0002
890 COGNITIVE DISORDER 8 0.0002
891 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
892 DIZZINESS 83 0.0002
893 GASTROENTERITIS VIRAL 3 0.0002
894 VERTIGO 10 0.0002
895 BLOOD GLUCOSE ABNORMAL 3 0.0002
896 LIMB DISCOMFORT 5 0.0002
897 EYE SWELLING 6 0.0002
898 PARAESTHESIA 25 0.0002
899 GASTRIC CANCER 4 0.0002
900 PRODUCT DOSE OMISSION ISSUE 46 0.0002
901 SKIN ULCER 4 0.0002
902 UNDERDOSE 11 0.0002
903 FUNGAL INFECTION 5 0.0001
904 IRRITABILITY 9 0.0001
905 THROAT TIGHTNESS 4 0.0001
906 OCULAR HYPERAEMIA 7 0.0001
907 VISION BLURRED 20 0.0001
908 TREATMENT FAILURE 12 0.0001
909 SKIN EXFOLIATION 12 0.0001
910 EYE PAIN 8 0.0001
911 EATING DISORDER 3 0.0001
912 DRY EYE 7 0.0001
913 ANGINA PECTORIS 4 0.0001
914 HYPOACUSIS 6 0.0001
915 INSOMNIA 37 0.0001
916 DRUG EFFECT INCOMPLETE 5 0.0001
917 FLUID RETENTION 7 0.0001
918 URTICARIA 23 0.0001
919 MALAISE 60 0.0001
920 NASAL CONGESTION 8 0.0001
921 INFLAMMATION 7 0.0001
922 DYSPEPSIA 13 0.0001
923 INJECTION SITE REACTION 9 0.0001
924 GAIT DISTURBANCE 25 0.0001
925 MOBILITY DECREASED 9 0.0001
926 ABDOMINAL DISCOMFORT 21 0.0001
927 IMPAIRED HEALING 4 0.0001
928 VISUAL IMPAIRMENT 15 0.0001
929 SKIN DISORDER 4 0.0001
930 MUSCLE SPASMS 22 0.0001
931 BONE PAIN 7 0.0001
932 WITHDRAWAL SYNDROME 5 0.0001
933 RECTAL HAEMORRHAGE 5 0.0001
934 PANCREATITIS 6 0.0001
935 ANGIOEDEMA 5 0.0001
936 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
937 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
938 TREATMENT NONCOMPLIANCE 6 0.0001
939 ACCIDENTAL OVERDOSE 4 0.0001
940 ABNORMAL DREAMS 3 0.0001
941 FALL 36 0.0001
942 BRONCHITIS 8 0.0001
943 OROPHARYNGEAL PAIN 10 0.0001
944 SWELLING FACE 7 0.0001
945 DEMENTIA 3 0.0001
946 PAIN IN EXTREMITY 31 0.0001
947 DISEASE RECURRENCE 5 0.0001
948 WEIGHT DECREASED 29 0.0001
949 OVERDOSE 22 0.0001
950 ALOPECIA 20 0.0001
951 ARTHRITIS 8 0.0001
952 ABNORMAL BEHAVIOUR 4 0.0001
953 LUNG NEOPLASM MALIGNANT 4 0.0001
954 DEPRESSED MOOD 5 0.0001
955 NO ADVERSE EVENT 17 0.0001
956 HAEMATOCHEZIA 5 0.0001
957 GAIT INABILITY 3 0.0001
958 FLATULENCE 5 0.0001
959 INFLUENZA LIKE ILLNESS 7 0.0001
960 BLOOD GLUCOSE DECREASED 4 0.0001
961 CONTUSION 8 0.0001
962 DYSGEUSIA 6 0.0001
963 AGGRESSION 4 0.0001
964 INTENTIONAL OVERDOSE 5 0.0001
965 ECZEMA 4 0.0001
966 PRODUCT USE ISSUE 14 0.0001
967 DRUG EFFECT DECREASED 4 0.0001
968 EXTRA DOSE ADMINISTERED 3 0.0001
969 BURNING SENSATION 5 0.0001
970 ARTHRALGIA 29 0.0001
971 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
972 DRY SKIN 9 0.0001
973 MYALGIA 11 0.0001
974 INJECTION SITE ERYTHEMA 8 0.0001
975 RHINORRHOEA 4 0.0001
976 RHEUMATOID ARTHRITIS 7 0.0001
977 NEOPLASM MALIGNANT 4 0.0001
978 MEMORY IMPAIRMENT 8 0.0001
979 COVID-19 10 0.0001
980 ADVERSE DRUG REACTION 5 0.0001
981 DISTURBANCE IN ATTENTION 3 0.0001
982 NASOPHARYNGITIS 10 0.0001
983 ARTHROPATHY 3 0.0001
984 WEIGHT INCREASED 12 0.0001
985 PERIPHERAL SWELLING 8 0.0001
986 INCORRECT DOSE ADMINISTERED 11 0.0000
987 DRUG ABUSE 4 0.0000
988 ACNE 3 0.0000
989 INJECTION SITE SWELLING 3 0.0000
990 SINUSITIS 4 0.0000
991 INJECTION SITE HAEMORRHAGE 3 0.0000
992 FEELING ABNORMAL 9 0.0000
993 INFLUENZA 4 0.0000
994 INJECTION SITE PAIN 9 0.0000
995 HOSPITALISATION 4 0.0000
996 DRUG DOSE OMISSION 4 0.0000